• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因组规模的文献综述:提高临床变异评估。

A literature review at genome scale: improving clinical variant assessment.

机构信息

Division of Genetics, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.

出版信息

Genet Med. 2018 Sep;20(9):936-941. doi: 10.1038/gim.2017.230. Epub 2018 Feb 1.

DOI:10.1038/gim.2017.230
PMID:29388949
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6070443/
Abstract

PURPOSE

Over 150,000 variants have been reported to cause Mendelian disease in the medical literature. It is still difficult to leverage this knowledge base in clinical practice, as many reports lack strong statistical evidence or may include false associations. Clinical laboratories assess whether these variants (along with newly observed variants that are adjacent to these published ones) underlie clinical disorders.

METHODS

We investigated whether citation data-including journal impact factor and the number of cited variants (NCV) in each gene with published disease associations-can be used to improve variant assessment.

RESULTS

Surprisingly, we found that impact factor is not predictive of pathogenicity, but the NCV score for each gene can provide statistical support for prediction of pathogenicity. When this gene-level citation metric is combined with variant-level evolutionary conservation and structural features, classification accuracy reaches 89.5%. Further, variants identified in clinical exome sequencing cases have higher NCVs than do simulated rare variants from the Exome Aggregation Consortium database within the same set of genes and functional consequences (P < 2.22  ×  10).

CONCLUSION

Aggregate citation data can complement existing variant-based predictive algorithms, and can boost their performance without the need to access and review large numbers of papers. The NCV is a slow-growing metric of scientific knowledge about each gene's association with disease.

摘要

目的

在医学文献中,已有超过 150,000 个变体被报道可导致孟德尔疾病。但由于许多报告缺乏强有力的统计证据,或者可能包含错误的关联,因此在临床实践中仍然难以利用这一知识库。临床实验室评估这些变体(以及与新观察到的、位于这些已发表变体附近的变体)是否是临床疾病的基础。

方法

我们研究了引用数据(包括期刊影响因子和每个具有发表疾病关联基因的引用变体数量(NCV))是否可用于改进变体评估。

结果

令人惊讶的是,我们发现影响因子不能预测致病性,但每个基因的 NCV 评分可以为致病性预测提供统计支持。当将这种基于基因的引用指标与基于变体的进化保守性和结构特征相结合时,分类准确性达到 89.5%。此外,在同一组基因和功能后果中,临床外显子组测序病例中鉴定的变体的 NCV 高于来自同一组基因和功能后果的 Exome Aggregation Consortium 数据库中的模拟罕见变体(P < 2.22 × 10)。

结论

综合引用数据可以补充现有的基于变体的预测算法,并在无需访问和审查大量论文的情况下提高其性能。NCV 是一个关于每个基因与疾病关联的科学知识的缓慢增长的指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/bb481d7145e0/nihms920084f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/ab3c58404696/nihms920084f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/8d98a73064d6/nihms920084f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/b6759fe3045b/nihms920084f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/bb481d7145e0/nihms920084f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/ab3c58404696/nihms920084f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/8d98a73064d6/nihms920084f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/b6759fe3045b/nihms920084f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4d37/6070443/bb481d7145e0/nihms920084f4.jpg

相似文献

1
A literature review at genome scale: improving clinical variant assessment.基因组规模的文献综述:提高临床变异评估。
Genet Med. 2018 Sep;20(9):936-941. doi: 10.1038/gim.2017.230. Epub 2018 Feb 1.
2
Identifying Mendelian disease genes with the variant effect scoring tool.使用变异效应评分工具鉴定孟德尔疾病基因。
BMC Genomics. 2013;14 Suppl 3(Suppl 3):S3. doi: 10.1186/1471-2164-14-S3-S3. Epub 2013 May 28.
3
Mitigating false-positive associations in rare disease gene discovery.减少罕见病基因发现中的假阳性关联。
Hum Mutat. 2015 Oct;36(10):998-1003. doi: 10.1002/humu.22847.
4
SEQSpark: A Complete Analysis Tool for Large-Scale Rare Variant Association Studies Using Whole-Genome and Exome Sequence Data.SEQSpark:一种使用全基因组和外显子组序列数据进行大规模罕见变异关联研究的完整分析工具。
Am J Hum Genet. 2017 Jul 6;101(1):115-122. doi: 10.1016/j.ajhg.2017.05.017. Epub 2017 Jun 29.
5
Imputation-based assessment of next generation rare exome variant arrays.基于插补法的新一代罕见外显子变异阵列评估
Pac Symp Biocomput. 2014:241-52.
6
How good are pathogenicity predictors in detecting benign variants?致病性预测因子在检测良性变异方面有多准确?
PLoS Comput Biol. 2019 Feb 11;15(2):e1006481. doi: 10.1371/journal.pcbi.1006481. eCollection 2019 Feb.
7
Rare disease variant curation from literature: assessing gaps with creatine transport deficiency in focus.从文献中挖掘罕见病变异体:以肌酸转运缺陷为重点评估差距。
BMC Genomics. 2023 Aug 16;24(1):460. doi: 10.1186/s12864-023-09561-5.
8
A visual and curatorial approach to clinical variant prioritization and disease gene discovery in genome-wide diagnostics.一种用于全基因组诊断中临床变异优先级排序和疾病基因发现的可视化与策展方法。
Genome Med. 2016 Feb 2;8(1):13. doi: 10.1186/s13073-016-0261-8.
9
Whole exome sequencing combined with integrated variant annotation prediction identifies asymptomatic Tangier disease with compound heterozygous mutations in ABCA1 gene.全外显子组测序结合整合变异注释预测鉴定出 ABCA1 基因复合杂合突变的无症状 Tangier 病。
Atherosclerosis. 2015 Jun;240(2):324-9. doi: 10.1016/j.atherosclerosis.2015.04.003. Epub 2015 Apr 7.
10
BioBin: a bioinformatics tool for automating the binning of rare variants using publicly available biological knowledge.BioBin:一个生物信息学工具,用于利用公开可用的生物知识自动对稀有变体进行分类。
BMC Med Genomics. 2013;6 Suppl 2(Suppl 2):S6. doi: 10.1186/1755-8794-6-S2-S6. Epub 2013 May 7.

引用本文的文献

1
Bibliometric Analysis of Research on Telomere Length in Children: A Review of Scientific Literature.端粒长度在儿童研究中的文献计量分析:科学文献综述。
Int J Environ Res Public Health. 2020 Jun 26;17(12):4593. doi: 10.3390/ijerph17124593.

本文引用的文献

1
Estimating the selective effects of heterozygous protein-truncating variants from human exome data.从人类外显子数据估计杂合蛋白截短变异的选择效应。
Nat Genet. 2017 May;49(5):806-810. doi: 10.1038/ng.3831. Epub 2017 Apr 3.
2
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
3
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.利用7855例心肌病病例和60706份参考样本重新评估孟德尔基因的致病性。
Genet Med. 2017 Feb;19(2):192-203. doi: 10.1038/gim.2016.90. Epub 2016 Aug 17.
4
The mutation significance cutoff: gene-level thresholds for variant predictions.突变意义截断值:变异预测的基因水平阈值。
Nat Methods. 2016 Feb;13(2):109-10. doi: 10.1038/nmeth.3739.
5
ClinGen--the Clinical Genome Resource.ClinGen——临床基因组资源。
N Engl J Med. 2015 Jun 4;372(23):2235-42. doi: 10.1056/NEJMsr1406261. Epub 2015 May 27.
6
Recursive splicing in long vertebrate genes.长脊椎动物基因中的递归剪接
Nature. 2015 May 21;521(7552):371-375. doi: 10.1038/nature14466. Epub 2015 May 13.
7
The evaluation of tools used to predict the impact of missense variants is hindered by two types of circularity.用于预测错义变异影响的工具评估受到两种循环性的阻碍。
Hum Mutat. 2015 May;36(5):513-23. doi: 10.1002/humu.22768. Epub 2015 Mar 26.
8
Clinical exome sequencing for genetic identification of rare Mendelian disorders.用于罕见孟德尔疾病基因鉴定的临床外显子组测序
JAMA. 2014 Nov 12;312(18):1880-7. doi: 10.1001/jama.2014.14604.
9
Molecular findings among patients referred for clinical whole-exome sequencing.接受临床全外显子组测序的患者的分子研究结果。
JAMA. 2014 Nov 12;312(18):1870-9. doi: 10.1001/jama.2014.14601.
10
A framework for the interpretation of de novo mutation in human disease.一种人类疾病中新生突变的解读框架。
Nat Genet. 2014 Sep;46(9):944-50. doi: 10.1038/ng.3050. Epub 2014 Aug 3.